Amphastar Pharmaceuticals, Inc. Common Stock (NASDAQ: AMPH) last traded at $26.76, up 0.53% on the session. The quote above updates while this page is open; the figures below are drawn from Amphastar Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Amphastar Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker AMPH. Its market capitalisation is $1.14 billion.
Valuation measures for Amphastar Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.14B |
|---|---|
| Enterprise value | $1.89B |
| P/E ratio | 15.83 |
| Price / sales | 1.56 |
| Price / book | 1.48 |
| Beta |
| 0.50 |
Trailing-twelve-month figures tagged in Amphastar Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $730.02M |
|---|---|
| Net income (TTM) | $78.55M |
| EPS (TTM) | $1.69 |
| Gross margin | 47.68% |
| Operating margin | 15.66% |
| Return on equity | 10.23% |
| Cash | $223.61M |
Range and volume for AMPH over the past 52 weeks.
| 52-week high | $29.52 |
|---|---|
| 52-week low | $16.65 |
| Volume | 362.8K |
| Average volume | 472.5K |
| Previous close | $26.62 |
Invest a chosen dollar amount in Amphastar Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AMPH.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.